Company / CapEx per Share
Ovid Therapeutics Inc. CapEx per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.02
FY2022-FY2025
Trend
+76.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.02 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -27.4%.
Declined from $0.02 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -27.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 76.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +76.7% |
| FY2024 | $0.00 | -96.7% |
| FY2023 | $0.02 | +564.4% |
| FY2022 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026